Jump to navigation
Disclose an Invention
UAVenture Capital, LLC has announced the launch of a fund to support the commercialization of University of Arizona science, services and intellectual property. UAVC was formed by Fletcher J. McCusker, the business driver behind the UA College of Pharmacy startup SinfoníaRx.
CALS Professors Vedantam and Viswanathan team up to develop prevention of and treatment for Clostridium difficile infection in humans and animals.
UA startup SinfoníaRx has been acquired by Tabula Rasa HealthCare (NASDAQ: TRHC), provider of individualized, data-driven technology solutions. Spun out of the College of Pharmacy in 2013, SinfoníaRx pioneered modern medication therapy management (MTM) services.
In October, the Arizona Bioindustry Association, or AZBio, will honor industry leaders from across Arizona. This year, a majority of those to be honored have deep connections to the UA and have created impact through bringing UA ideas and inventions to the marketplace.
UA College of Engineering faculty Pierre Deymier and Keith Runge have developed an alternative to the standard quantum computing bits, which can greatly improve a system's speed and stability.
The University of Arizona has licensed a new non-skin penetrating sunscreen, invented by UA Professor Douglas Loy and graduate student Stephanie Tolbert, to MexiAloe Laboratorios, S.A. de C.V., a subsidiary of Novamex.
The UA center will use the funding to accelerate development of a Valley fever vaccine for dogs that one day may lead to a successful human vaccine.
Since TLA started in 2012, we have met or exceeded our goals year over year, and are seeing continued growth in the impact originally envisioned for commercialization at the UA. We did it again in FY2017 thanks to your engagement as inventors, experts, advisors and supporters.
The University of Arizona has licensed a pair of technologies to startup Lunewave, Inc. The company is commercializing the College of Engineering inventions to improve automotive radar systems with inexpensive, high-performing 3D printed Luneburg lenses.
UA College of Medicine-Tucson faculty Dr. Monica Kraft and Dr. Julie Ledford have developed a novel treatment for asthma and other lung-related diseases via a series of peptides related to surfactant protein A (SP-A).